Abstract
The ICP-AES technique was developed for rhenium determination in the range of 0.00002 - 0.05 % in copper and molybdenum ores along with their concentrates. The sample pretreatment method by sintering with magnesium oxide and oxidizing agents was offered for analysis; optimum conditions for samples digestion were established. These conditions enabled to pass rhenium into solution with no losses. Matrix influence on rhenium emission spectral lines was studied and methods were investigated to eliminate matrix effects. The analysis results of rhenium-containing ores and concentrates certificated reference materials and mixtures on their basis, obtained by the developed procedure, agreed well with the certified rhenium content values.
Keywords: Rhenium, inductively coupled plasma atomic emission spectral analysis, internal standard, sintering, copper and molybdenum concentrates and ores.
Graphical Abstract
Current Analytical Chemistry
Title:The Rhenium Determination in Copper and Molybdenum Ores and Concentrates by ICP Atomic Emission Spectrometry
Volume: 10 Issue: 4
Author(s): Olga Evdokimova, Polina Zaitceva, Nadezhda Pechishcheva, Alexandr Pupyshev and Konstantin Shunyaev
Affiliation:
Keywords: Rhenium, inductively coupled plasma atomic emission spectral analysis, internal standard, sintering, copper and molybdenum concentrates and ores.
Abstract: The ICP-AES technique was developed for rhenium determination in the range of 0.00002 - 0.05 % in copper and molybdenum ores along with their concentrates. The sample pretreatment method by sintering with magnesium oxide and oxidizing agents was offered for analysis; optimum conditions for samples digestion were established. These conditions enabled to pass rhenium into solution with no losses. Matrix influence on rhenium emission spectral lines was studied and methods were investigated to eliminate matrix effects. The analysis results of rhenium-containing ores and concentrates certificated reference materials and mixtures on their basis, obtained by the developed procedure, agreed well with the certified rhenium content values.
Export Options
About this article
Cite this article as:
Evdokimova Olga, Zaitceva Polina, Pechishcheva Nadezhda, Pupyshev Alexandr and Shunyaev Konstantin, The Rhenium Determination in Copper and Molybdenum Ores and Concentrates by ICP Atomic Emission Spectrometry, Current Analytical Chemistry 2014; 10 (4) . https://dx.doi.org/10.2174/157341101004140701102351
DOI https://dx.doi.org/10.2174/157341101004140701102351 |
Print ISSN 1573-4110 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6727 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Bioactivity of New μ and δ Opioid Peptides
Medicinal Chemistry PLGA Nanoparticles and Polysorbate-80-Coated PLGA Nanoparticles Increase the In vitro Antioxidant Activity of Melatonin
Current Drug Delivery Therapeutic Potential of Cinnoline Core: A Comprehensive Review
Mini-Reviews in Medicinal Chemistry Meet Our Co-Editor
Mini-Reviews in Medicinal Chemistry Synthetic Approaches to the 2006 New Drugs
Mini-Reviews in Medicinal Chemistry Drug Likeness and Selective Functionalization of Quinoxalines
Current Organic Synthesis Microvascular Diseases: Is A New Era Coming?
Cardiovascular & Hematological Agents in Medicinal Chemistry Acute Myocarditis in Children: An Overview of Treatment and Recent Patents
Recent Patents on Inflammation & Allergy Drug Discovery Nerve Growth Factor and Brain-Derived Neurotrophic Factor in Schizophrenia and Depression: Findings in Humans, and Animal Models
Current Neuropharmacology Molecular Mimicry in Autoimmune Neurological Disease after Viral Infection
Current Medicinal Chemistry Serotonergic Drugs: Agonists/Antagonists at Specific Serotonergic Subreceptors for the Treatment of Cognitive, Depressant and Psychotic Symptoms in Alzheimer’s Disease
Current Pharmaceutical Design Extracellular Vesicles as Novel Delivery Tools for Cancer Treatment
Current Cancer Drug Targets Editorial [ New Advances in Alzheimers Disease: From Biology to Therapy Guest Editor: Giuseppina Tesco ]
Current Genomics The Association between Migratory Factors and Emotional and Behavioural Symptoms in Very Recently Arrived Immigrant and Refugee Adolescents
Adolescent Psychiatry Vaccine Development for Alzheimers Disease
Current Pharmaceutical Design The State of the Art on the Use of Oral Fluid as Alternative Specimen in Forensic Toxicology
Current Pharmaceutical Analysis Reward-Seeking Behavior and Addiction: Cause or Cog?
Current Drug Abuse Reviews Current Approaches for Drug Delivery to Central Nervous System
Current Drug Delivery Nano Prussian Yellow Film Modified Electrode: A Cathode Material for Aqueous Potassium Ion Secondary Battery with Zinc Anode
Current Nanoscience Lentiviral Vectors: A Powerful Tool to Target Astrocytes In Vivo
Current Drug Targets